Correction to: Prostate Cancer and Prostatic Diseases https://doi.org/10.1038/s41391-023-00713-y, published online 26 August 2023
In Table 2 of this article, the unit for CTAG1A and KLK2 were incorrect and should have read pg/ml and ng/ml respectively.
The incorrect Table 2
The corrected Table 2
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Csizmarik, A., Nagy, N., Keresztes, D. et al. Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer. Prostate Cancer Prostatic Dis (2025). https://doi.org/10.1038/s41391-025-01064-6
Published:
Version of record:
DOI: https://doi.org/10.1038/s41391-025-01064-6
